BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The BioCalendar - ECPv6.17.5//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://thebiocalendar.com
X-WR-CALDESC:Events for The BioCalendar
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260831
DTEND;VALUE=DATE:20260901
DTSTAMP:20260504T221917Z
CREATED:20260504T221917Z
LAST-MODIFIED:20260504T221917Z
UID:10339-1788134400-1788220799@thebiocalendar.com
SUMMARY:ESC Congress 2026
DESCRIPTION:Join us and experience transformation through practice\, policy\, responsibility and genuine human connection. \nThis year’s Spotlight on Artificial Intelligence explores how AI is becoming a co-pilot\, enhancing precision\, speed\, and safety in patient care. Discover AI in action\, from diagnosis to delivery\, through hands-on sessions\, live demonstrations\, and immersive learning. \nHere we will explore a diverse range of topics\, uniting all subspecialties to create a space to share breakthrough data and debate new ideas\, before applying innovation to real-world settings. \nThis is where collaboration becomes progress\, and transformation is not just seen\, but felt.
URL:https://thebiocalendar.com/event/esc-congress-2026/
LOCATION:Munich\, Munich\, Bavaria\, Germany
CATEGORIES:Seminar,Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260901
DTEND;VALUE=DATE:20260903
DTSTAMP:20260709T104118Z
CREATED:20260709T104118Z
LAST-MODIFIED:20260709T104118Z
UID:10750-1788220800-1788393599@thebiocalendar.com
SUMMARY:Hubs West
DESCRIPTION:The Hub and Specialty Pharmacy Model conference series returns to sunny San Diego\, CA at the stunning Estancia La Jolla Hotel & Spa. Demand for agile\, scalable and innovative programs are at an all time high as market dynamics continue to evolve and regulatory changes remains unclear. This event brings together top industry experts to equip you with cutting-edge technologies and actionable insights to enhance patient outcomes. Hub and Specialty Pharmacy Models West is the premier event for professionals seeking unparalleled networking opportunities and expert-driven content to refine their hub strategies and elevate their patient services suite.
URL:https://thebiocalendar.com/event/hubs-west/
LOCATION:San Diego\, San Diego\, CA\, United States
CATEGORIES:Networking,Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260902T110000
DTEND;TZID=America/Los_Angeles:20260902T120000
DTSTAMP:20260812T085616Z
CREATED:20260805T154159Z
LAST-MODIFIED:20260812T085616Z
UID:10924-1788346800-1788350400@thebiocalendar.com
SUMMARY:AI-Readiness in a Regulated World: A Practical Playbook for Life Sciences
DESCRIPTION:In this practical session\, Jake Walton\, VP of Quality & Compliance at MasterControl\, will share a candid look at how MasterControl approached AI the right way from the start—building human-in-the-loop architecture as a non-negotiable design principle\, aligning every capability to 21 CFR Part 11\, EU MDR\, GDPR\, HIPAA\, and other applicable standards\, and going all the way through ISO 42001 certification for Artificial Intelligence Management Systems.
URL:https://thebiocalendar.com/event/ai-readiness-in-a-regulated-world-a-practical-playbook-for-life-sciences/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/08/09-02-26-MasterControl-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260902T110000
DTEND;TZID=America/Los_Angeles:20260902T120000
DTSTAMP:20260812T085636Z
CREATED:20260805T160301Z
LAST-MODIFIED:20260812T085636Z
UID:10929-1788346800-1788350400@thebiocalendar.com
SUMMARY:A CCS is a purpose-built machine\, not a black box: Understand the workings
DESCRIPTION:A contamination control strategy (CCS) is usually treated as a document with sixteen elements assembled\, signed\, and shelved. This webinar offers a new perspective of a CCS as a machine that is not so complex that it cannot be analyzed component by component.
URL:https://thebiocalendar.com/event/a-ccs-is-a-purpose-built-machine-not-a-black-box-understand-the-workings-2/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/08/09-02-25-CAI-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260902T110000
DTEND;TZID=America/Los_Angeles:20260902T120000
DTSTAMP:20260812T085657Z
CREATED:20260805T181245Z
LAST-MODIFIED:20260812T085657Z
UID:10936-1788346800-1788350400@thebiocalendar.com
SUMMARY:Enabling the full potential of process chromatography
DESCRIPTION:Successfully scaling a purification process from development to GMP manufacturing requires maintaining process performance while minimizing variability. However\, scale-up often introduces challenges that can impact productivity\, recovery\, and overall process efficiency. To mitigate risk\, manufacturers frequently apply conservative safety factors during scale-up—resulting in lower resin utilization\, increased buffer consumption\, longer process times\, and reduced overall productivity. \nWhat if you could maintain the same critical process parameters (CPPs) and critical quality attributes (CQAs) from bench scale through commercial manufacturing with greater confidence and control? \nJoin Repligen for an in-depth discussion on how advanced process control and real-time analytics can help close the gap between process development and manufacturing performance. \nThis webinar will explore key considerations for implementing real-time monitoring and control strategies in chromatography processes. Industry experts will discuss the capabilities of the KRM® chromatography platform and the integration of FlowVPX® Process Analytical Technology (PAT) for in-line product concentration measurement. \nAttendees will learn how these technologies can be applied to support process characterization\, monitor purification performance\, and generate data that may inform scale-up and manufacturing decisions while maintaining focus on critical quality attributes. \nWhat You’ll Learn: \nWhy purification processes often lose efficiency during scale-up\nHow improved process accuracy and precision can increase yield and productivity\nBest practices for maintaining CPPs and CQAs from development through GMP manufacturing\nHow the KRM® platform supports advanced chromatography process control\nHow integrated FlowVPX® PAT enables real-time concentration monitoring and process optimization\nStrategies to improve resin utilization\, reduce buffer consumption\, and maximize recovery \nWho Should Attend? \nProcess Development Scientists\nDownstream Process Engineers\nManufacturing Scientists\nMSAT Professionals\nBiologics and Cell & Gene Therapy Professionals\nPurification and Chromatography Specialists \nRegister Today \nDiscover how real-time process analytics and intelligent chromatography control can help you achieve higher yields\, greater process consistency\, improved resin utilization\, and increased manufacturing productivity—without compromising product quality.
URL:https://thebiocalendar.com/event/enabling-the-full-potential-of-process-chromatography/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/08/09-02-26-Repligen-Reg-1920x250-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260908T160000
DTEND;TZID=America/Los_Angeles:20260908T170000
DTSTAMP:20260812T085719Z
CREATED:20260805T181903Z
LAST-MODIFIED:20260812T085719Z
UID:10946-1788883200-1788886800@thebiocalendar.com
SUMMARY:Beyond breakdowns: Building a culture of proactive maintenance
DESCRIPTION:Across biopharma operations\, reactive “run‑to‑failure” maintenance is one of the biggest hidden drivers of downtime\, deviations\, and escalating lifecycle cost. As the industry moves toward digital maturity\, organizations are shifting from calendar‑based activities to proactive\, engineering‑driven practices that eliminate root causes\, strengthen compliance\, and create the foundation for future predictive and prescriptive strategies. \nProactive maintenance focuses on precision\, consistency\, and early intervention—addressing the mechanical\, procedural\, and environmental factors that lead to recurring failures. This approach not only reduces unplanned downtime and costly emergency service but also supports audit readiness through clear documentation and alignment with Original Equipment Manufacturer (OEM) best practices. For most sites\, these fundamentals deliver the fastest\, highest‑ROI reliability gains long before advanced analytics or AI‑driven tools come into play. \nJoin our session to explore how proactive maintenance can significantly improve equipment uptime\, operational resilience\, and regulatory confidence while preparing your organization for the next stages of digital reliability. \nIn this session\, you will: \nUnderstand the maintenance maturity pyramid and how to intentionally progress through each level\nLearn how proactive\, hands‑on maintenance practices reduce failures and improve cost efficiency\nExplore how lifecycle management integrates with preventive\, proactive\, and predictive strategies\nGain practical tips for implementing proactive maintenance today—and preparing for a predictive or prescriptive culture in the future
URL:https://thebiocalendar.com/event/beyond-breakdowns-building-a-culture-of-proactive-maintenance/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/08/09-08-26-Cytiva-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260909T110000
DTEND;TZID=America/New_York:20260909T120000
DTSTAMP:20260812T085742Z
CREATED:20260810T191003Z
LAST-MODIFIED:20260812T085742Z
UID:11005-1788951600-1788955200@thebiocalendar.com
SUMMARY:How to Achieve Stable\, High-Output Stickpack Production
DESCRIPTION:The key to unlocking maximum OEE? Integrating dosing accuracy\, platen sealing\, magnetic shuttle transport\, and automated 100% in-line quality control into a unified workflow. \nJoin our virtual event\, “How to Achieve Stable\, High-Output Stickpack Production” with packaging expert René Schubert (Körber Pharma). \nWhy you can’t afford to miss this:\n– Discover how integrated stickpack & cartoning lines simplify operations.\n– Learn technology levers (platen sealing\, magnetic shuttle transport) that slash waste and boost uptime.\n– Future-proof your facility for regulatory compliance and sustainability goals.
URL:https://thebiocalendar.com/event/how-to-achieve-stable-high-output-stickpack-production/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/08/09-09-26-Koerber-eBlast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260910
DTEND;VALUE=DATE:20260911
DTSTAMP:20260819T134535Z
CREATED:20260819T134535Z
LAST-MODIFIED:20260819T134535Z
UID:11096-1788998400-1789084799@thebiocalendar.com
SUMMARY:Biocom’s HR Conference for Life Science - Northern California
DESCRIPTION:Biocom invites you to attend our HR Conference for Life Science held in-person on September 10 at The Forum in South San Francisco. Join us to form meaningful connections\, elevate your practices as a human resources leader and gain the tools and insights needed to create a positive\, lasting impact within organizations of all sizes.
URL:https://thebiocalendar.com/event/biocoms-hr-conference-for-life-science-northern-california/
LOCATION:South San Francisco\, CA\, CA\, 94080\, United States
CATEGORIES:Forum
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260910T110000
DTEND;TZID=America/Los_Angeles:20260910T120000
DTSTAMP:20260812T085808Z
CREATED:20260805T181605Z
LAST-MODIFIED:20260812T085808Z
UID:10941-1789038000-1789041600@thebiocalendar.com
SUMMARY:Scaling Next-Gen MSC Therapies Without Scaling Risk
DESCRIPTION:Mesenchymal stromal cell (MSC) therapies are entering a pivotal stage of development. As more programs move toward late-stage clinical trials and commercialization\, developers must produce enough high-quality cells to meet growing demand while maintaining potency\, consistency\, and manufacturability. How can companies scale MSC production without compromising the biological properties that drive therapeutic efficacy? \nJoin Cell & Gene’s Chief Editor\, Erin Harris\, for this Cell & Gene Live discussion featuring Miguel Forte\, M.D.\, Ph.D.\, CEO of Kiji Therapeutics\, Silviu Itescu\, M.D.\, Founder\, CEO\, and Managing Director of Mesoblast\, and Edward Ahn\, Ph.D.\, CEO of MEDIPOST. Together\, these experts bring decades of experience developing\, manufacturing\, and commercializing MSC therapies. Their combined expertise spans early innovation\, scalable manufacturing\, and commercial execution. \nThe expert panel will discuss strategies for scaling MSC therapies while minimizing donor variability\, preserving potency\, improving process consistency\, and building commercially viable manufacturing platforms. They will also examine advances in cell sourcing\, process development\, quality systems\, and manufacturing strategy. Attendees will leave with practical insights into what developers should prioritize today to improve their products’ chances of clinical and commercial success. \nRegistration is free.
URL:https://thebiocalendar.com/event/scaling-next-gen-msc-therapies-without-scaling-risk/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/08/26_09_CGL-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260910T110000
DTEND;TZID=America/Los_Angeles:20260910T120000
DTSTAMP:20260817T231840Z
CREATED:20260813T125211Z
LAST-MODIFIED:20260817T231840Z
UID:11060-1789038000-1789041600@thebiocalendar.com
SUMMARY:Autonomous Impinging Jet Mixing for LNP Process Development
DESCRIPTION:Lipid nanoparticles (LNPs) are critical to the delivery of genetic medicines\, but developing scalable\, reproducible manufacturing processes remains complex and resource-intensive. Because LNP quality can be highly sensitive to formulation and processing conditions\, identifying the right parameters efficiently is essential. \nThis webinar will explore how impinging jet mixing\, automation\, inline analytics\, and data-driven optimization can accelerate LNP process development. Attendees will see how automated design of experiments\, dynamic process sweeps\, self-optimization\, and predictive modeling can help map process-property relationships and identify conditions that achieve target quality attributes.
URL:https://thebiocalendar.com/event/autonomous-impinging-jet-mixing-for-lnp-process-development/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/08/09-10-26-Knauer-eBlast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260910T110000
DTEND;TZID=America/New_York:20260910T130000
DTSTAMP:20260831T230525Z
CREATED:20260811T193706Z
LAST-MODIFIED:20260831T230525Z
UID:11017-1789038000-1789045200@thebiocalendar.com
SUMMARY:BVS’ Longwood Galleria Tech Vendor Expo at the Inn at Longwood\, Boston
DESCRIPTION:We are very excited to announce that this premier Expo will occur at The Inn at Longwood\, Longwood Hall centrally located in the food court at the hotel. \nMark your calendars for a great opportunity to connect with industry leaders\, explore innovative products\, and mingle with fellow professionals in the biotech community. \nThis event will attract researchers from the many institutions situated in the Longwood medical area that include the following: Harvard Medical School\, Harvard School of Public Health\, Dana Farber Cancer Institute\, Boston Children’s Hospital\, Brigham & Women’s Hospital and Beth Israel Deaconess Hospital. \n✨ What to Expect: \nVendor Exhibits: Discover a diverse range of exhibitors showcasing cutting-edge technology and services in the biotech space.\nNetworking Opportunities: Engage with fellow industry experts\, forge new connections\, and exchange ideas that could shape the future of biotech.\nDelicious Food & Drinks: Enjoy delicious refreshments as you network and explore the vendor exhibits. \nAdmission Details:\nFREE for life science job-related employees (including researchers\, scientists\, purchasing\, clinical\, manufacturing\, non-sales/bus dev positions etc.) from life science companies and research institutes.\n$200 fee for product and service providers who sell to the life science community (e.g. BVS suppliers\, business development/sales\, marketing\, lawyers\, consultants)\, which includes access to the event but does not include an exhibitor table. Exhibitor tables can be purchased separately. \nFor exhibitor tables\, please visit our website and register at: https://bvsconnection.com/events \nPlease feel free to invite others in the community that could benefit from attending. \nWe look forward to seeing you there!
URL:https://thebiocalendar.com/event/bvs-longwood-galleria-tech-vendor-expo-at-the-inn-at-longwood-3/
LOCATION:Boston\, MA\, 02210\, United States
CATEGORIES:Expo,Trade Show
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2026/08/BVS-Biotech-Event-Flyer-09-10-26-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260910T150000
DTEND;TZID=America/Los_Angeles:20260910T180000
DTSTAMP:20260901T104938Z
CREATED:20260901T104938Z
LAST-MODIFIED:20260901T104938Z
UID:11199-1789052400-1789063200@thebiocalendar.com
SUMMARY:CRADL® Connect Happy Hour – Meet. Collaborate. Accelerate.
DESCRIPTION:Join Charles River at our Torrey Heights CRADL® location for an evening of networking\, collaboration\, and connection with biotech and pharmaceutical professionals from across San Diego’s thriving life sciences ecosystem. \nWhether you’re a current CRADL resident\, building an emerging biotech company\, expanding your research operations\, or exploring new laboratory solutions\, CRADL Connect offers a unique opportunity to forge meaningful industry relationships in a relaxed and engaging environment. \n\nPlease note\, this event is by invitation only and advanced registration is required. \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nWhy Attend? \n\n\n\n\n\n\n\n\n\n\n\n\n• Meet leaders from biotech and pharmaceutical organizations across San Diego \n• Connect with fellow CRADL residents and emerging companies \n• Exchange ideas with scientists\, founders\, and business leaders \n• Explore opportunities for future collaborations\, partnerships\, and growth \n• Discover the CRADL Advantage
URL:https://thebiocalendar.com/event/cradl-connect-happy-hour-meet-collaborate-accelerate/
LOCATION:San Diego\, San Diego\, CA\, United States
CATEGORIES:Networking,Social
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260911T110000
DTEND;TZID=America/Los_Angeles:20260911T120000
DTSTAMP:20260812T085847Z
CREATED:20260805T182248Z
LAST-MODIFIED:20260812T085847Z
UID:10951-1789124400-1789128000@thebiocalendar.com
SUMMARY:De-Risking Cell Culture Media Scale-Up for Late-Stage Manufacturing
DESCRIPTION:Strategies for supply assurance\, QC readiness\, digital optimization\, and commercial bioprocessing success. \nThe translation of cell culture processes from laboratory-scale development to commercial manufacturing remains one of the most critical challenges in bioprocessing. While small-scale systems provide valuable insights into cell growth\, productivity\, and product quality\, scale-up introduces complex engineering and biological variables that can significantly impact process performance. Scale-up also comes with additional considerations that can greatly impact efficiency\, cost and speed-to-market. \nIn this webinar\, a panel of experienced professionals from Thermo Fisher Scientific will explore potential challenges encountered during cell culture media manufacturing scale-up\, options and solutions. A sample of topics will include: \nSupply assurance—approaches to help ensure transparent and uninterrupted global supply of your cell culture media\nBenefits of granular cell culture media formats\, including preparation time productivity and financial savings models\nManaging emerging QC considerations to meet new regulatory requirements\nHow digital tools are helping change how media formulations are designed and optimized\nCase study real-world examples of how Thermo Fisher has worked with customers to successfully navigate late-stage media manufacturing \nThis session includes a Q and A with our presenters immediately following the presentation.
URL:https://thebiocalendar.com/event/de-risking-cell-culture-media-scale-up-for-late-stage-manufacturing/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/08/09-11-26-Thermo-Reg-1920x250-0.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260914
DTEND;VALUE=DATE:20260916
DTSTAMP:20260504T222100Z
CREATED:20260504T222100Z
LAST-MODIFIED:20260504T222100Z
UID:10340-1789344000-1789516799@thebiocalendar.com
SUMMARY:Drug Delivery & Formulation Summit
DESCRIPTION:The 16th American Drug Delivery & Formulation will once again bring together an exceptional line-up of the industry’s best speakers\, with technical experts\, industry leaders\, and specialists providing an unmissable two days of the latest information. \nNow in its 16th year\, the summit continues to go from strength to strength. Last year saw a record number of attendees with over 450 scientific leaders from pharma\, biotech\, and drug delivery industries. \nThose in attendance will benefit from a packed two-day programme\, where they will explore the critical issues with the industry’s best speakers. There will be plentiful networking times\, expect to meet fellow industry leaders\, enabling meetings\, connections\, and business growth.
URL:https://thebiocalendar.com/event/drug-delivery-formulation-summit/
LOCATION:Boston\, MA\, 02210\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260914
DTEND;VALUE=DATE:20260918
DTSTAMP:20260617T130743Z
CREATED:20260617T130743Z
LAST-MODIFIED:20260617T130743Z
UID:10629-1789344000-1789689599@thebiocalendar.com
SUMMARY:Fierce Pharma Week
DESCRIPTION:Fierce Pharma Week is a major annual conference and networking event for the life sciences industry\, produced by Fierce Pharma. It brings together thousands of pharmaceutical and biotech decision-makers—including C-suite executives\, marketing leaders\, PR teams\, and medical affairs professionals—to shape the future of commercial\, scientific\, and communications strategies.
URL:https://thebiocalendar.com/event/fierce-pharma-week/
LOCATION:Philadelphia\, Philadelphia\, PA\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260914
DTEND;VALUE=DATE:20260917
DTSTAMP:20260727T213626Z
CREATED:20260701T193131Z
LAST-MODIFIED:20260727T213626Z
UID:10725-1789344000-1789603199@thebiocalendar.com
SUMMARY:AGBT Precision Health Meeting
DESCRIPTION:AGBT Precision Health\, taking place September 14-16\, 2026\, at the Loews Coronado Bay Resort\, San Diego\, California\, brings together leaders across genomics\, healthcare\, AI\, and biotechnology to explore how emerging technologies are transforming precision medicine and clinical care. \n\n\n  \n\n\nWhy Attend? \n\nConnect with researchers\, clinicians\, industry innovators\, investors\, and policymakers in intimate networking settings designed to encourage conversation and exchange of ideas.\nLearn from leading voices across genomics\, including Niall Lennon\, recipient of a GUINNESS WORLD RECORDS™ title for the fastest DNA sequencing technique.\nExplore new collaborations\, partnerships\, and business opportunities.\n\nAbstract Submissions and Next Gen Leadership Awards \nResearchers are invited to submit cutting-edge work across precision health\, genomics\, AI\, diagnostics\, rare disease\, translational medicine\, and related fields. Selected abstracts may be featured as poster presentations\, flash talks\, and oral presentations throughout the meeting program. \nWe also encourage graduate students\, postdoctoral researchers\, and other early-career professionals to apply for the AGBT Next Gen Leadership Award Program. Selected participants will receive travel support\, hotel accommodations\, and complimentary registration. \nSponsorship and Exhibitor Opportunities \nAGBT Precision Health provides direct access to a highly engaged audience of scientific leaders\, clinicians\, healthcare innovators\, and industry decision-makers driving the future of precision medicine. Increase brand visibility\, showcase innovations\, and connect with key decision-makers. \nKey Dates to keep in mind: \n\nAbstract Submission Deadline: July 21\, 2026\nNext Gen Leadership Award applications close: July 21\, 2026\nEarly Bird Rates Close: August 3rd\, 2026\n\nIf you’re considering attending\, submitting an abstract\, or exploring sponsorship or exhibitor opportunities\, click on this link: https://www.agbtprecisionhealth.org
URL:https://thebiocalendar.com/event/the-2026-agbt-precision-health-meeting/
LOCATION:Loews Coronado Bay Resort\, 4000 Coronado Bay Road\, Coronado\, 92118\, United States
CATEGORIES:Forum,Summit,Symposium
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260914
DTEND;VALUE=DATE:20260915
DTSTAMP:20260721T185250Z
CREATED:20260721T185249Z
LAST-MODIFIED:20260721T185250Z
UID:10829-1789344000-1789430399@thebiocalendar.com
SUMMARY:Partnerships with Sites Summit
DESCRIPTION:How can sponsors\, CROs\, and sites adapt to improve enrollment and retention in a changing clinical trial environment?  \n\n\n\n\n\n\n\n\n\nThe Partnerships with Sites Summit challenges how sponsors\, CROs\, and sites adapt to a rapidly evolving clinical trial ecosystem shaped by shifts in the global site landscape\, increasing study complexity\, evolving technology\, and changing operating models. These forces are reshaping clinical trial execution and placing new demands on consistency\, coordination\, and performance across the system. \n\n\nAs the role of sites continues to evolve\, the summit brings stakeholders together to rethink how trials are designed and executed in this new environment—where execution determines enrollment and retention outcomes. \n\n\nThe summit focuses on the key forces shaping this inflection point:  \n\n\n\nIncreasing variability across site types is challenging consistent trial execution\n\n\n\n\nRising protocol complexity and operational demands are straining coordination and site capacity\n\n\n\n\nFragmented technology adoption is creating workflow inefficiencies across studies and systems\n\n\n\n\nMisaligned operating models are driving variability in startup timelines\, delivery\, and performance outcomes\n\n\n\n\nEarlier alignment on study design\, governance\, and execution expectations is becoming critical to improving feasibility and consistency
URL:https://thebiocalendar.com/event/partnerships-with-sites-summit/
LOCATION:Boston\, MA\, 02210\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260914
DTEND;VALUE=DATE:20260917
DTSTAMP:20260819T144427Z
CREATED:20260819T144427Z
LAST-MODIFIED:20260819T144427Z
UID:11117-1789344000-1789603199@thebiocalendar.com
SUMMARY:The Charles River Biotech Symposium
DESCRIPTION:The Charles River Biotech Symposium unites drug development professionals in an interactive setting to discuss the nonclinical development of biotherapeutics\, including regulatory issues and innovative approaches to problem-solving. The collegial spirit of this meeting creates exceptional opportunities for information sharing and networking.  \nRegister today to save your seat for an event aimed to inspire\, educate\, and connect you with the opinion leaders shaping the future of biotherapeutics.  Learn from their successes and failures\, how unexpected obstacles were overcome\, and hear stories of their interactions with the FDA. \nDon’t miss “Cross the Barrier: Targeted Tissue Delivery of Biologics” the optional workshop on Sunday\, September 13\, 2026 when making your travel plans.
URL:https://thebiocalendar.com/event/the-charles-river-biotech-symposium/
LOCATION:San Diego\, San Diego\, CA\, United States
CATEGORIES:Symposium
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260914T110000
DTEND;TZID=America/Los_Angeles:20260914T120000
DTSTAMP:20260817T231855Z
CREATED:20260812T195344Z
LAST-MODIFIED:20260817T231855Z
UID:11053-1789383600-1789387200@thebiocalendar.com
SUMMARY:Driving Productivity Across the Antibody Manufacturing Workflow
DESCRIPTION:Join us for an exclusive webinar exploring practical strategies to improve therapeutic antibody manufacturing through integrated upstream and downstream process solutions. As therapeutic antibody titers continue to rise\, manufacturers face increasing pressure to remove harvest bottlenecks\, improve purification efficiency\, and maintain product quality while controlling manufacturing costs. Successfully integrating upstream and downstream operations has become essential for improving throughput and enabling scalable commercial manufacturing. \nIn this webinar\, Thermo Fisher Scientific experts will feature a case study highlighting innovative single-use harvest and clarification technologies\, along with practical approaches to downstream purification process optimization. \nDuring this webinar\, you will learn:\n~ How integrated upstream and downstream solutions can support therapeutic antibody process development and scale-up\n~ How Thermo Scientific™ DynaSpin™ Single-Use Centrifuge and Harvest RC™ Chromatographic Clarifier technologies can simplify harvest operations while maintaining product quality\n~ Case study data demonstrating scalable harvest clarification from development through manufacturing\, including process performance and economic modelling\n~ Practical downstream optimization strategies\, including Protein A capture optimization\, polishing simplification\, and flexible purification approaches \nWho should attend: \nBioprocess scientists and engineers\nUpstream and downstream process development teams\nManufacturing Science & Technology (MSAT) professionals\nProcess development managers\nTechnical operations and manufacturing professionals\nCDMO\, biotech\, and biopharmaceutical organizations
URL:https://thebiocalendar.com/event/driving-productivity-across-the-antibody-manufacturing-workflow/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/08/09-14-26-Thermo-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260914T110000
DTEND;TZID=America/Los_Angeles:20260914T120000
DTSTAMP:20260831T214434Z
CREATED:20260831T214434Z
LAST-MODIFIED:20260831T214434Z
UID:11189-1789383600-1789387200@thebiocalendar.com
SUMMARY:Future-Proofing Your USP  Strategy: Preparing for the Next Generation of Biological Reactivity Testing
DESCRIPTION:As the December 1\, 2026 release of the revised USP <87>\, Biological Reactivity Tests\, In Vitro\, approaches\, pharmaceutical and medical device manufacturers should begin evaluating how these changes may impact their material qualification\, biological evaluation\, and compliance strategies. While the final chapter has not yet been published\, the proposed direction reflects a broader industry shift toward modern\, science-based in vitro testing approaches\, quantitative data generation\, and risk-based assessment methodologies. \nJoin Pace® Life Sciences for an informative webinar exploring what organizations can expect from the upcoming revisions\, how evolving regulatory expectations may influence testing programs\, and practical steps to prepare before implementation. Our scientific experts will discuss anticipated changes\, the potential impact on qualification and validation activities\, and how proactive planning can help ensure a smooth transition while maintaining compliance and operational efficiency. \nKey learning objectives: \n\nUnderstand the anticipated revisions to USP <87> and how they reflect the industry’s shift toward modern\, science-based in vitro biological reactivity testing\nEvaluate the potential impact on your organization by exploring how the revised chapter may affect material qualification\, biological evaluation strategies\, validation activities\, and regulatory documentation\nLearn practical steps to prepare for implementation by developing a proactive strategy for testing readiness\, laboratory planning\, and compliance before the revised chapter is released
URL:https://thebiocalendar.com/event/future-proofing-your-usp-strategy-preparing-for-the-next-generation-of-biological-reactivity-testing/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/08/091426_pace_reg_1920x250_0.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260915
DTEND;VALUE=DATE:20260917
DTSTAMP:20260721T185754Z
CREATED:20260721T185408Z
LAST-MODIFIED:20260721T185754Z
UID:10831-1789430400-1789603199@thebiocalendar.com
SUMMARY:16th Annual DPHARM
DESCRIPTION:Connecting 1\,000+ Industry Executives\, Innovators\, and Change-Makers \n\n\n\n\n\n\n\n\nThe 16th Annual DPHARM® will offer an unparalleled opportunity to hear senior clinical operations executives and innovative thought leaders unveil the latest innovations on modernizing clinical trials. \nDPHARM speakers report on R&D industry innovation that drives greater efficiencies and accelerates clinical trials for the benefit of patients. \nDPHARM 2026 features senior clinical operation executives with industry and patient thought leadership\, and technologists showcasing the latest innovations in clinical trials driving efficiencies in operational processes and reducing patient\, site and physician burden to participating in research.​​​​​​​
URL:https://thebiocalendar.com/event/16th-annual-dpharm/
LOCATION:Boston\, MA\, 02210\, United States
CATEGORIES:Summit,Symposium
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260915
DTEND;VALUE=DATE:20260918
DTSTAMP:20260819T143749Z
CREATED:20260819T143749Z
LAST-MODIFIED:20260819T143749Z
UID:11105-1789430400-1789689599@thebiocalendar.com
SUMMARY:12th Annual BHCR Week
DESCRIPTION:The 12th Annual BioHealth Capital Region Week returns September 15–17\, 2026\, at US Pharmacopeia in Rockville\, Maryland\, bringing together leaders from industry\, academia\, government\, investment\, and entrepreneurship for three days of programming\, networking\, and regional collaboration. \nThis year’s theme\, “Growing the BioHealth Capital Region of Tomorrow\,” reflects the work needed now to strengthen commercialization\, expand access to capital\, build new partnerships\, and support the next generation of biohealth companies. As organizations across the ecosystem navigate a more uncertain funding environment\, BHCR Week provides a place for the region to come together around shared priorities and future growth. \nThe week includes the BioHealth Capital Region Forum\, the Crab Trap Competition\, and the BioHealth Capital Region Investment Conferenc
URL:https://thebiocalendar.com/event/12th-annual-bhcr-week/
LOCATION:Rockville\, MD\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260915T110000
DTEND;TZID=America/Los_Angeles:20260915T120000
DTSTAMP:20260812T085901Z
CREATED:20260810T175809Z
LAST-MODIFIED:20260812T085901Z
UID:10992-1789470000-1789473600@thebiocalendar.com
SUMMARY:Crossing The Valley Of Death: New Funding Options For Preclinical And Early-Stage Drug Development
DESCRIPTION:A risk-averse investment climate has made it more difficult for startups to find the funding needed to bring novel treatments into the clinic. However\, alternative funding sources\, investment models\, and nontraditional investors are stepping in to fill the void. Our panel of experts will identify and discuss new funding opportunities and strategies for companies at preclinical and the early stages of clinical development.
URL:https://thebiocalendar.com/event/crossing-the-valley-of-death-new-funding-options-for-preclinical-and-early-stage-drug-development/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/08/09-15-26-LSL-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260916T100000
DTEND;TZID=America/Los_Angeles:20260916T110000
DTSTAMP:20260812T085919Z
CREATED:20260806T174539Z
LAST-MODIFIED:20260812T085919Z
UID:10965-1789552800-1789556400@thebiocalendar.com
SUMMARY:Virtual Pharma Expo: Oral Solid Dose Manufacturing & Packaging
DESCRIPTION:Virtual Pharma Expo – a themed event featuring presentations and demonstrations by leading experts from pharmaceutical equipment providers for oral solid dose manufacturing and packaging.
URL:https://thebiocalendar.com/event/virtual-pharma-expo-oral-solid-dose-manufacturing-packaging/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/08/09-2026-VPE-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260917T110000
DTEND;TZID=America/New_York:20260917T120000
DTSTAMP:20260817T231914Z
CREATED:20260813T173402Z
LAST-MODIFIED:20260817T231914Z
UID:11065-1789642800-1789646400@thebiocalendar.com
SUMMARY:Injected And Connected? Digital Strategies For Raising Delivery IQ
DESCRIPTION:Innovations in self-administered and wearable drug delivery technologies promise convenience but bring questions about how to effectively monitor and manage patient safety\, adherence\, dosing accuracy\, and\, ultimately\, medical outcomes. In this live online session\, expert panelists will discuss approaches to leveraging the power of digital tools to provide feedback loops and administrative controls. From both strategic and practical perspectives\, the panel will address biopharma product development considerations. This is a free event; click to learn more.
URL:https://thebiocalendar.com/event/injected-and-connected-digital-strategies-for-raising-delivery-iq/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/08/26_09-DDL-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260918T110000
DTEND;TZID=America/Los_Angeles:20260918T120000
DTSTAMP:20260812T085937Z
CREATED:20260807T180605Z
LAST-MODIFIED:20260812T085937Z
UID:10971-1789729200-1789732800@thebiocalendar.com
SUMMARY:Making The Jump To GMP: Material Decisions For Clinical Manufacturing
DESCRIPTION:Transitioning development processes into GMP manufacturing can come with a fair share of growing pains. Development teams need to contend with things like sourcing and validating new materials\, ensuring regulatory compliance\, performing risk assessments\, and evaluating facility fit. Unexpected challenges in any aspect of this transition can be costly and delay a product’s time to enter the clinic. \nJoin Bioprocess Online’s Tyler Menichiello for an interactive panel discussion on phase-appropriate CMC decisions and material selection for GMP readiness. This conversation will feature Wei Lu\, Ph.D.\, a senior staff bioprocess engineer at Takeda; Tiffany Rau\, Ph.D.\, owner and principal consultant at Bio Pharma Technical Consulting; and Mary Rodley\, an independent consultant with Medius Consulting\, LLC. These experts will focus on the challenge of sourcing and implementing GMP-grade materials and equipment in a process for the first time. \nWhether you’re in the throes of transitioning into clinical manufacturing or are preparing to do so\, this event will identify the key considerations and choices that matter the most.
URL:https://thebiocalendar.com/event/making-the-jump-to-gmp-material-decisions-for-clinical-manufacturing/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2026/08/26_09-BPOL-LinkedIn-1280x720-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260921T110000
DTEND;TZID=America/Los_Angeles:20260921T120000
DTSTAMP:20260831T214603Z
CREATED:20260831T214603Z
LAST-MODIFIED:20260831T214603Z
UID:11193-1789988400-1789992000@thebiocalendar.com
SUMMARY:Beyond the Starting Material: Building a Path to GMP Manufacturing Success
DESCRIPTION:For cell therapy developers\, manufacturing success starts well before a process enters a GMP cleanroom. Decisions around donor and material sourcing\, collection strategy\, starting material specifications\, process development\, and analytical strategy can directly influence process consistency\, technology transfer\, and manufacturing readiness. \nJoin technical experts from New York Blood Center Enterprises’ Comprehensive Cell Solutions (CCS) team for a practical discussion on connecting cellular starting materials with downstream process development and GMP manufacturing. Drawing on real-world experience across sourcing\, collections\, process and analytical development\, technology transfer\, and clinical manufacturing\, the panel will highlight key considerations and common challenges that arise as programs move from early development toward the clinic through commercialization. \nThe discussion will explore how teams can better align starting material requirements with the manufacturing process\, establish appropriate controls and specifications\, prepare processes for successful technology transfer\, and build a more reliable path into GMP manufacturing. Attendees will leave with practical considerations for reducing variability\, anticipating manufacturing challenges\, and making development decisions with later-stage requirements in mind. \nKey Learning Objectives \n\nUnderstand the role of starting material in process performance and how donor criteria\, collection strategy\, material attributes\, and variability should be considered during development\nIdentify key considerations when moving a process into GMP manufacturing\, including process and analytical readiness\, technology transfer\, facility fit\, and operational execution\nLearn how early development decisions can support later-stage manufacturing\, helping teams anticipate risks\, improve process robustness\, and prepare for clinical and commercial requirements
URL:https://thebiocalendar.com/event/beyond-the-starting-material-building-a-path-to-gmp-manufacturing-success/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/08/092126_comprehensive_reg_1920x250_0.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260922
DTEND;VALUE=DATE:20260926
DTSTAMP:20260817T222738Z
CREATED:20260324T074629Z
LAST-MODIFIED:20260817T222738Z
UID:10064-1790035200-1790380799@thebiocalendar.com
SUMMARY:Biotech Week Boston 2026
DESCRIPTION:Be a Part of the Conversation at Biotech Week Boston 2026\n  \n\n\n\n\n\nConnect with the full biopharmaceutical ecosystem – Biotech\, Academia\, Investors and Service Providers\nWhere C-Suite and Science come together to drive business and innovation\n3200+ global attendees from 35 countries under one roof
URL:https://thebiocalendar.com/event/biotech-week-boston-2026/
LOCATION:Boston\, MA\, 02210\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260922
DTEND;VALUE=DATE:20260923
DTSTAMP:20260709T104235Z
CREATED:20260709T104235Z
LAST-MODIFIED:20260709T104235Z
UID:10752-1790035200-1790121599@thebiocalendar.com
SUMMARY:Life Sciences Product Launch Summit
DESCRIPTION:The Life Sciences Product Launch Summit is a premier event designed to empower professionals in pharma and biotech commercialization with the tools and strategies needed to craft the ultimate launch playbook. This summit is essential for navigating the complexities of product launches in a dynamic and competitive marketplace. Attendees will gain exclusive insights into creating a comprehensive playbook that addresses critical aspects such as market access hurdles\, innovative pricing strategies and aligning portfolio strategies with unmet market needs.
URL:https://thebiocalendar.com/event/life-sciences-product-launch-summit/
LOCATION:Boston\, MA\, 02210\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260922
DTEND;VALUE=DATE:20260924
DTSTAMP:20260819T143950Z
CREATED:20260819T143950Z
LAST-MODIFIED:20260819T143950Z
UID:11107-1790035200-1790207999@thebiocalendar.com
SUMMARY:World Medical Innovation Forum
DESCRIPTION:A Global Forum for Healthcare Innovation Decision-Makers \n\n\n\n\n\n\n\n\n\n\nThe World Medical Innovation Forum convenes the center of healthcare innovation — senior industry executives\, top investors\, leading Harvard clinicians and scientists\, entrepreneurs\, and government officials. \nCandid dialogue and collaboration accelerate how healthcare innovation moves from discovery to clinical adoption and real-world impact.
URL:https://thebiocalendar.com/event/world-medical-innovation-forum-2/
LOCATION:Boston\, MA\, 02210\, United States
CATEGORIES:Forum
END:VEVENT
END:VCALENDAR